These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9211403)

  • 1. Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells.
    Gualandris A; Lopez Conejo T; Giunciuglio D; Albini A; Sabini E; Rusnati M; Dell'Era P; Presta M
    Microvasc Res; 1997 May; 53(3):254-60. PubMed ID: 9211403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2.
    Giuliani R; Bastaki M; Coltrini D; Presta M
    J Cell Sci; 1999 Aug; 112 ( Pt 15)():2597-606. PubMed ID: 10393815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis.
    Sandberg T; Casslén B; Gustavsson B; Benraad TJ
    Biol Reprod; 1998 Oct; 59(4):759-67. PubMed ID: 9746723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.
    Okusa Y; Ichikura T; Mochizuki H; Shinomiya N
    Int J Oncol; 2000 Nov; 17(5):1001-5. PubMed ID: 11029504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2.
    Ribatti D; Leali D; Vacca A; Giuliani R; Gualandris A; Roncali L; Nolli ML; Presta M
    J Cell Sci; 1999 Dec; 112 ( Pt 23)():4213-21. PubMed ID: 10564640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
    Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.
    Basire A; Sabatier F; Ravet S; Lamy E; Mialhe A; Zabouo G; Paul P; Gurewich V; Sampol J; Dignat-George F
    Thromb Haemost; 2006 Apr; 95(4):678-88. PubMed ID: 16601839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of cell-surface urokinase-type plasminogen activator activity and cell migration in vascular endothelial cells by a novel hexapeptide analogue of neurotensin.
    Ushiro S; Mizoguchi K; Yoshida S; Jimi S; Fujiwara T; Yoshida M; Wei ET; Kitabgi P; Amagaya S; Ono M; Kuwano M
    FEBS Lett; 1997 Dec; 418(3):341-5. PubMed ID: 9428741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
    Schnaper HW; Barnathan ES; Mazar A; Maheshwari S; Ellis S; Cortez SL; Baricos WH; Kleinman HK
    J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
    Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H; Sheng S
    Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.
    Pepper MS; Vassalli JD; Montesano R; Orci L
    J Cell Biol; 1987 Dec; 105(6 Pt 1):2535-41. PubMed ID: 3121633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells.
    Rusnati M; Dell'Era P; Urbinati C; Tanghetti E; Massardi ML; Nagamine Y; Monti E; Presta M
    Mol Biol Cell; 1996 Mar; 7(3):369-81. PubMed ID: 8868466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells.
    Takahashi K; Uwabe Y; Sawasaki Y; Kiguchi T; Nakamura H; Kashiwabara K; Yagyu H; Matsuoka T
    Am J Physiol; 1998 Jul; 275(1):L47-54. PubMed ID: 9688934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and role of urokinase plasminogen activator in vascular remodelling.
    Tkachuk V; Stepanova V; Little PJ; Bobik A
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells.
    Kojima S; Hayashi S; Shimokado K; Suzuki Y; Shimada J; Crippa MP; Friedman SL
    Blood; 2000 Feb; 95(4):1309-16. PubMed ID: 10666204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
    Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
    J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.